Two Sigma Securities, LLC Fsd Pharma Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.99 - $2.04 $11,978 - $24,681	-12,099 Reduced 54.34%	10,165 $11,000
Q1 2023 May 15, 2023	BUY	$0.77 - $1.81 $17,143 - $40,297	22,264 New	22,264 $34,000
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.1 $12,836 - $18,102	-16,457 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.82 - $1.1 $4 - $6	6 Added 0.04%	16,457 $14,000
Q4 2021 Feb 14, 2022	BUY	$0.96 - $1.63 $15,792 - $26,815	16,451 New	16,451 $17,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.35M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.